IView-1201 Phase II IND application for the Treatment of Adenoviral Conjunctivitis Accepted by US FDA

By

IView-1201 Phase II IND application for the Treatment of Adenoviral Conjunctivitis Accepted by US FDA

See more here

Comments are closed.